Novartis plots new course for Sandoz

During his first full year earnings readout as CEO of Novartis AG (NYSE:NVS; SIX:NOVN), Vasant Narasimhan said the company intends to turn Sandoz into "an autonomous entity over the next 18 months that is able to compete as an independent

Read the full 406 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE